Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report

dc.creatorVillafañe, Jorge Hugo
dc.creatorSilva, Guillermo Benjamin
dc.creatorChiarotto, Alessandro
dc.creatorRagusa, Orazio L. F.
dc.date2012-07
dc.date.accessioned2023-08-31T00:38:58Z
dc.date.available2023-08-31T00:38:58Z
dc.identifierhttp://hdl.handle.net/11336/197262
dc.identifierVillafañe, Jorge Hugo; Silva, Guillermo Benjamin; Chiarotto, Alessandro; Ragusa, Orazio L. F.; Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report; Elsevier; Journal of Chiropractic Medicine; 11; 3; 7-2012; 186-191
dc.identifier1556-3707
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8543646
dc.descriptionObjective: The purpose of this study is to report a case in which combinatory therapy of botulinum toxin type A (BoNT-A) and neurodynamic mobilization (NM) was used as treatment for a patient with severe upper limb spasticity and pain after stroke. Clinical Features: A 76-year-old male patient had spastic muscles in the upper limb 10 months after an ischemic stroke. Intervention and Outcome: The patient underwent combined treatment with BoNT-A and NM of the upper limb in 6 monthly applications. Evaluation was performed pretreatment, 3 months after the first injection, 3 months after the second injection, and at a follow-up session 9 months after starting the treatment. The following outcomes were measured: pain by using a numeric rating scale, spasticity by the Modified Ashworth Scale for Grading Spasticity, acceptance and emotional reaction to the treatment by the Hospital Anxiety and Depression Scale, and functionality by ranges of motion. The patient improved in all outcomes after treatment, and results were maintained during the follow-up sessions. Conclusion: The combined NM and BoNT-A treatment appeared to decrease pain and improve joint ranges of motion during treatment for this patient. The patient showed decreased anxiety and depression during and after the treatment.
dc.descriptionFil: Villafañe, Jorge Hugo. Universidad Rey Juan Carlos; España
dc.descriptionFil: Silva, Guillermo Benjamin. Universidad Católica de Córdoba. Facultad de Ciencias Químicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba; Argentina
dc.descriptionFil: Chiarotto, Alessandro. Universidad Rey Juan Carlos; España
dc.descriptionFil: Ragusa, Orazio L. F.. No especifíca;
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S155637071200079X
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.jcm.2012.05.009
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subjectBOTULINUM TOXIN TYPE A
dc.subjectMUSCLE SPASTICITY
dc.subjectPHYSIOTHERAPY
dc.subjectSTROKE
dc.subjecthttps://purl.org/becyt/ford/3.2
dc.subjecthttps://purl.org/becyt/ford/3
dc.titleBotulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución